| abstract |
The present invention provides administering to a subject at risk for, or suspected of having or suffering from myocardial damage, an effective amount of plasminogen. And methods for preventing or treating the same. The present invention further relates to drugs, drug compositions, products and kits containing plasminogen for preventing and / or treating myocardial damage and related diseases in subjects. |